Injectable Drug Delivery Devices Market Study Highlights How Industry Demand Is Evolving
The Business Research Company's Injectable Drug Delivery Devices Market Report 2026 – Market Size, Trends, And Global
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
The Business Research Company’s Injectable Drug Delivery Devices Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, August 12, 2026 /EINPresswire.com/ — “The market for injectable drug delivery devices has witnessed significant expansion in recent years, reflecting growing demand driven by advancements in medical technology and changing healthcare needs. As the landscape of drug administration evolves, this sector is poised for continued growth, shaped by various factors including chronic disease prevalence and innovation in delivery methods.
Market Size and Growth Trajectory of the Injectable Drug Delivery Devices Market
The injectable drug delivery devices market has experienced robust growth, with its size projected to rise from $54.3 billion in 2025 to $58.69 billion in 2026, representing a compound annual growth rate (CAGR) of 8.1%. This upward trend during the past years has been fueled by the increasing incidence of chronic diseases, the expansion of biologics and biosimilars, a greater number of hospital-administered injectable therapies, improvements in sterile manufacturing processes, and broader accessibility to injection devices. Looking further ahead, the market is expected to reach $79.51 billion by 2030, growing at a CAGR of 7.9%. Key drivers of this forecast include a shift toward self-administration devices, heightened demand for personalized drug delivery solutions, a growing pipeline of biologic drugs, rising investments in smart injection technologies, and expanded adoption of home healthcare services. Emerging trends set to influence the market encompass the increased use of prefilled and safety syringes, growing popularity of autoinjectors and pen injectors, the rise of home-based injectable treatments, as well as the development of wearable and implantable infusion pumps, all supported by a strong emphasis on dose accuracy and patient safety.
Download a free sample of the injectable drug delivery devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR
Understanding Injectable Drug Delivery Devices and Their Applications
Injectable drug delivery devices are medical instruments designed to administer medications directly into the body via injection. These devices facilitate various administration routes including intravenous, subcutaneous, intradermal, intra-peritoneal, and intramuscular injections, enabling precise and effective drug delivery for a wide range of therapeutic needs.
Rising Prevalence of Chronic Diseases as a Market Driver
A major factor propelling the global injectable drug delivery devices market is the growing prevalence of chronic diseases, which are long-lasting health conditions persisting for three months or more and often worsening over time. These devices provide a dependable and convenient means for delivering medication over extended periods, improving patient adherence to treatment plans. Enhanced compliance ensures better management of chronic illnesses and results in improved health outcomes. For example, in June 2024, the UK’s National Health Service reported that 3,615,330 individuals registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% rise from 3,065,825 cases in 2022. Such data highlights the increasing burden of chronic conditions, which in turn drives demand for injectable drug delivery solutions.
View the full injectable drug delivery devices market report:
https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR
Regional Leadership and Growth Outlook in the Injectable Drug Delivery Devices Market
In 2025, North America held the position as the largest regional market for injectable drug delivery devices. However, Asia-Pacific is projected to be the fastest-growing region over the forecast period. The market analysis also encompasses other key areas, including South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global developments and opportunities within this sector.
New analytical features added to our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()
Media gallery
